Immunoglobulin G1 (IgG1) is a type of antibody that plays a crucial role in the immune response, specifically in recognizing and binding to antigens. The substance in question, anti-(human carcinoembryonic antigen) (CEA), is a mouse monoclonal antibody that targets CEA, a glycoprotein often overexpressed in certain cancers, making it a significant biomarker in oncology. The designation "ZCE025" refers to a specific clone of this antibody, which is produced by hybridoma technology. The dimeric form indicates that two antibody molecules are linked, typically through disulfide bonds, enhancing stability and functionality. The γ1-chain refers to the heavy chain of the IgG1 isotype, while the light chain is also derived from the same monoclonal source. This antibody is utilized in various diagnostic and therapeutic applications, including immunohistochemistry and targeted therapy, due to its specificity and ability to elicit immune responses against tumor cells expressing CEA. Its CAS number, 156586-92-4, uniquely identifies this specific antibody formulation in chemical databases.

Immunoglobulin G1, anti-(human carcinoembryonic antigen) (mouse monoclonal ZCE025 γ1-chain), disulfide with mouse monoclonal ZCE025 light chain, dimer

156586-92-4: Immunoglobulin G1 (IgG1) is a type of antibody that plays a crucial role in the immune response, specifically in recognizing and binding to antigens. The substance in question, anti-(human carcinoembryonic antigen) (CEA), is a mouse monoclonal antibody that targets CEA, a glycoprotein often overexpressed in certain cancers, making it a significant biomarker in oncology. The designation "ZCE025" refers to a specific clone of this antibody, which is produced by hybridoma technology. The dimeric form indicates that two antibody molecules are linked, typically through disulfide bonds, enhancing stability and functionality. The γ1-chain refers to the heavy chain of the IgG1 isotype, while the light chain is also derived from the same monoclonal source. This antibody is utilized in various diagnostic and therapeutic applications, including immunohistochemistry and targeted therapy, due to its specificity and ability to elicit immune responses against tumor cells expressing CEA. Its CAS number, 156586-92-4, uniquely identifies this specific antibody formulation in chemical databases.

CAS 156586-92-4

Immunoglobulin G1, anti-(human carcinoembryonic antigen) (mouse monoclonal ZCE025 γ1-chain), disulfide with mouse monoclonal ZCE025 light chain, dimer

Altumomab

Ref: 3D-CLA1234